The Rise In Pharmaceutical R&D Spending Fueling Market Growth Due To Increasing Investment In Drug Innovation Is Supporting Development Across The Animal Model Market

The Business Research Company’s 2026 market reports feature advanced enhancements such as market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, delivering more actionable and strategically valuable research.

What Is The Forecasted Rise In Market Size Of The Animal Model Market During The Forecast Period?

The animal model market has shown significant growth in recent years. It is projected to expand from $2.07 billion in 2025 to $2.24 billion in 2026, reflecting a compound annual growth rate (CAGR) of 8.5%. The historical increase can be attributed to the rising prevalence of chronic diseases, increased demand for preclinical research, advancements in pharmaceutical R&D, technological improvements in laboratory equipment, and the broadening of academic research institutions.

The animal model market size is anticipated to experience substantial growth in the upcoming years. It is projected to expand to $2.97 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 7.3%. This expansion during the forecast period is attributable to the adoption of AI and machine learning in preclinical studies, the rise of precision medicine initiatives, the growth of CROs and outsourcing, the expansion of genetically modified animal models, and an increased focus on translational research. Significant trends identified for this period include advanced animal model development, genetically engineered models, high-throughput screening in preclinical studies, the integration of imaging and diagnostic tools, and the continued expansion of contract research organizations.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=15510&type=smp

Which Growth Factors Are Strengthening The Animal Model Market Landscape?

Future expansion of the animal model market is anticipated, driven by increasing investment in pharmaceutical research and development (R&D). This R&D encompasses the discovery, development, and testing of novel therapies, demanding thorough preclinical investigations to assess safety, effectiveness, and biological pathways prior to human clinical trials. The surge in R&D expenditure stems from an escalating demand for groundbreaking treatments, the rising occurrence of intricate diseases, and ongoing scientific progress. Within this framework, animal models serve a vital function by offering dependable preclinical platforms that replicate human physiological conditions, thus allowing for the predictive evaluation of drug efficacy. A notable example is provided by the European Federation of Pharmaceutical Industries and Associations, a Belgium-based trade group, which reported in November 2023 that pharmaceutical industry R&D spending climbed to 50,000 million in 2023, an increase from 47,010 million in 2022. Consequently, the increasing expenditure on pharmaceutical R&D is a key factor propelling the expansion of the animal model market.

How Are Different Segment Groups Identified Within The Animal Model Market?

The animal model market covered in this report is segmented –

1) By Animal Type: Mice, Rat, Guinea Pigs, Rabbits, Hamsters, Other Animal Types

2) By Technology: Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR), Embryonic Stem Cell Injection, Nuclear Transfer, Other Technologies

3) By Application: Drug Discovery And Development, Basic Research, Other Applications

4) By End User: Research Institutes, Educational Institutes, Pharmaceutical Companies, Contract Research Organizations

Subsegments:

1) By Mice: Inbred Mice, Outbred Mice, Knockout Mice, Transgenic Mice

2) By Rat: Inbred Rats, Outbred Rats, Transgenic Rats, Knockout Rats

3) By Guinea Pigs: Standard Guinea Pigs, Immunodeficient Guinea Pigs

4) By Rabbits: New Zealand White Rabbits, Dutch Belted Rabbits, Other Rabbit Breeds

5) By Hamsters: Syrian Hamsters, Chinese Hamsters

6) By Other Animal Types: Non-Human Primates (Monkeys, Chimpanzees), Dogs, Pigs, Sheep, Ferrets, Other Small Animals (Ferrets, Gerbils)

Which Trends Are Expected To Shape The Animal Model Market?

Leading companies operating within the animal model market are strategically focusing on the creation of advanced products, including triple-immunodeficient animal models. This effort aims to boost the accuracy and reliability of preclinical studies, support sophisticated biomedical research, and accelerate the development of new treatments for complex human diseases. Triple-immunodeficient animal models are specifically engineered animals, typically mice, that lack three crucial components of the immune system. These models offer immense value in biomedical research, particularly for understanding human illnesses and formulating new therapies. For example, in January 2024, Charles River Laboratories International, Inc., a US-based pharmaceutical company, introduced NCG mouse strains, which represent a triple-immunodeficient mouse model for oncology research. NCG mice are characterized by their triple immunodeficiency, being devoid of functional/mature T, B, and NK cells, and also displaying reduced macrophage and dendritic cell function. These animal models are capable of hosting xenograft cells, tissues, and human immune system components. This mouse model is exceptionally well-suited for investigations in oncology, immunology, tumor biology, infectious diseases, graft-versus-host disease (GvHD), diabetes, regenerative medicine, hematopoiesis, and tissue transplant studies. Moreover, NCG mice can be used to generate humanized mice through the engraftment of PBMCs or CD34+ stem cells, thereby closely mirroring the human immune system.

Who Are The Businesses Driving Activity In The Animal Model Market?

Major companies operating in the animal model market are Eurofins Scientific SE, Charles River Laboratories International Inc., Pharmaron Beijing Co Ltd, Inotiv Inc., Biocytogen, Taconic Biosciences Incorporation, Cyagen Biosciences, Trans Genic Incorporation, Crown Bioscience Incorporation, Harbor BioMed, PharmaLegacy, PsychoGenics, Biomere Biomedical Research Models Inc., Genoway S.A, Alloy Therapeutics, Janvier Labs, Hera Biolabs, Ozgene Pty Ltd, Transposagen Biopharmaceuticals Inc., KMT Hepatech Inc., AniLocus Inc., BioXpert, Harlan Sprague Dawley Inc.

Access The Complete Animal Model Market Report:

https://www.thebusinessresearchcompany.com/report/animal-model-global-market-report

Which Region Is The Primary Market For The Animal Model Market?

North America was the largest region in the animal model market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the animal model market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Access Animal Model Market Report for Deeper Competitive Insights

https://www.thebusinessresearchcompany.com/sample.aspx?id=15510&type=smp

Browse Through More Reports Similar to the Global Animal Model Market 2026, By The Business Research Company

Animal Model Market Report 2026

https://www.thebusinessresearchcompany.com/report/animal-model-global-market-report

Rat Model Market Report 2026

https://www.thebusinessresearchcompany.com/report/rat-model-global-market-report

Anatomical Models Market Report 2026

https://www.thebusinessresearchcompany.com/report/anatomical-models-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795